Chen et al. assessed the diagnostic accuracy of plasma samples for early lung cancer based on promoter methylation in 8 lung cancer-specific genes (CDO1, TAC1, SOX17, HOXA7, HOXA9, GATA4, GATA5, and PAX5) in plasma samples. This evidence concerns the gene PAX5 and lung carcinoma.